GSIT vs IMMR

GSIT presents a paradoxical financial profile: an exceptionally strong balance sheet paired with severe operational inefficiency. While the Piotroski F-Score of 4/9 indicates stable health and the current ratio of 10.42 shows massive liquidity, the company suffers from a -113.66% operating margin and a high Price/Sales ratio of 8.21. The combination of heavy insider selling by the CEO and officers, alongside a recent 34.9% monthly price collapse, suggests a lack of confidence in near-term profitability. Despite modest revenue growth, the lack of a positive Graham Number or intrinsic value baseline makes the current valuation speculative.

IMMR presents a classic 'deep value' paradox: it is fundamentally undervalued based on the Graham Number ($19.63) and Intrinsic Value ($13.3), yet it is plagued by a total collapse in technical momentum (0/100). The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while a negative operating margin (-8.03%) suggests that strong revenue growth (59.2%) is not yet translating into operational efficiency. While the dividend is exceptionally safe with a 7.11% payout ratio, the recent massive earnings miss (-382.1% surprise) and consistent price decline suggest a value trap until a catalyst emerges.